Chase AIPricingFAQs
Display currency
Loading news…

SightMD

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Hauppauge, New York, United States Founded 2021 251-500 employees For Profit

SightMD provides ophthalmology and eye care services, including cataract treatment, LASIK procedures, and vision care.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
2
Monthly Visits
Available in Pro
Contacts
147

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
28
Active products
13
IT spend
$1.54M

Company Info

Founded
2021
Employees
251-500
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
Sub-organizations
1
News articles
76
HQ
Hauppauge, New York, United States
Region
Greater New York Area, East Coast, Northeastern US

Signals & Scores

Heat score
High
Growth score
Low
Trend (7d)
0
Trend (30d)
-0.9
Trend (90d)
-1.4
Last leadership hire
Apr 1, 2026

Acquisitions by SightMD

Loading columns…
0 of 0Show
Page 1 / 1

Key People at SightMD

Co-Founder & President
147
professional contacts at SightMD
Contact execs at SightMD

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to SightMD

Loading news…

FAQs about SightMD

People who checked this page also checked these

Sectors SightMD invests & acquires in

M&A by year

Browse the full Acquirezy directory.